https://clinicaltrials.gov/ct2/show/NCT04515719?type=Intr&cond=Lupus&phase=012345&lupd_s=08%2F03%2F2020&lupd_d=14
Condition : Systemic Lupus Erythematosus
Interventions : Biological: Belimumab; Biological: Placebo
Sponsor : RenJi Hospital
Not yet recruiting
Efficacy and Safety of Belimumab in SLE Patients
NCT04515719
Mon, 17 Aug 2020 12:00:00 EDT
